Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05978141 · ClinicalTrials.gov registry record

A Registry for People With T-cell Lymphoma

A clinical trial of T-Cell Lymphoma and T-cell-prolymphocytic Leukemia, sponsored by Memorial Sloan Kettering Cancer Center.

Recruiting
Registry status
1,000
Enrollment target
20
Study locations

NCT05978141: Recruiting study of T-Cell Lymphoma and T-cell-prolymphocytic Leukemia, sponsored by Memorial Sloan Kettering Cancer Center.

NCT05978141 is a study of T-Cell Lymphoma and T-cell-prolymphocytic Leukemia that is actively recruiting participants, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 1,000 participants, above the 68-participant average among 15 other T-Cell Lymphoma trials with a reported enrollment target (1371% higher). The trial reports 20 study locations across 12 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05978141, a study of T-Cell Lymphoma and T-cell-prolymphocytic Leukemia, is actively recruiting participants, sponsored by Memorial Sloan Kettering Cancer Center.

RECRUITING
Registry status
1,000 participants
Enrollment target
20
Study locations

Study Summary

The purpose of this registry study is to create a database-a collection of information-for better understanding T-cell lymphoma. Researchers will use the information from this database to learn more about how to improve outcomes for people with T-cell lymphoma.

Primary Outcome

To develop and populate a secure database comprised of patients with T-cell lymphomas with curated clinical characteristics and treatment outcomes matched to pathological biospecimens.

Conditions Studied

T-Cell Lymphoma T-cell-prolymphocytic Leukemia T-cell Large Granular Lymphocytic Leukemia NK-Cell Lymphoma Aggressive NK-cell Leukemia Hydroa Vacciniforme-Like Lymphoproliferative Disorder Chronic Lymphoproliferative Disorder of NK Cells Systemic Epstein-Barr Virus Positive T-Cell Lymphoproliferative Disease of Childhood (Disorder) Chronic Active EBV Infection of T-and NK-Cell Type, Systemic Form

Interventions

  • OTHER Optional Blood Sample and Nail Sample

Study Locations (20)

California

  • City of Hope Cancer Center (Data collection only) - Duarte
  • UNIVERSITY OF CALIFORNIA SAN DIEGO (Data collection only) - San Diego
  • University of California San Francisco (Data collection only) - San Francisco
  • Stanford University Medical Center (Data collection only) - Stanford

New York

  • Memorial Sloan Kettering Cancer Center @ Suffolk-Commack (All protocol activities) - Commack
  • Memorial Sloan Kettering Westchester (All protocol activities) - Harrison
  • Weill Cornell Medical Center (Data Collection Only) - New York

Florida

  • University of Miami (Data Collection Only) - Miami
  • Moffitt Cancer Center (Data Collection Only) - Tampa

Massachusetts

  • Massachusetts General Hospital (Data Collection Only) - Boston
  • Dana Farber Cancer Institute (Data Collection Only) - Boston

New Jersey

  • Memorial Sloan Kettering at Basking Ridge (All protocol activities) - Basking Ridge
  • Memorial Sloan Kettering Monmouth (All protocol activities) - Middletown

Colorado

  • University of Colorado (Data Collection Only) - Aurora

Connecticut

  • Yale University (Data Collection Only) - New Haven

Georgia

  • Emory University (Data Collection Only) - Atlanta

Trial Details

FieldValue
Enrollment Target 1,000 participants
Start Date 2023-07-27
Est. Completion 2030-07-27
Memorial Sloan Kettering Cancer Center

1,884 total trials

What NCT05978141 shows while recruiting

NCT05978141 is an observational study that tracks outcomes without assigning an intervention. Its 1,000 participants enrollment target places it among the larger protocols in the corpus, above the 68-participant average among 15 other T-Cell Lymphoma trials with a reported enrollment target (1371% higher).

The record links to 9 conditions, with T-Cell Lymphoma appearing as the primary indexed condition, and to 1 intervention - of which Optional Blood Sample and Nail Sample is the first listed.

NCT05978141 names 20 study sites across 12 states, led by California, New York, Florida.

Frequently Asked Questions

What is clinical trial NCT05978141 about?

NCT05978141 is a clinical study titled "A Registry for People With T-cell Lymphoma". The purpose of this registry study is to create a database-a collection of information-for better understanding T-cell lymphoma. Researchers will use the information from this database to learn more about how to improve outcomes for people with T-cell lymphoma.

What is the current status of trial NCT05978141?

This trial is currently recruiting. The enrollment target is 1,000 participants. The study started on 2023-07-27. Estimated completion is 2030-07-27.

What conditions does trial NCT05978141 study?

This clinical trial studies the following conditions: T-Cell Lymphoma, T-cell-prolymphocytic Leukemia, T-cell Large Granular Lymphocytic Leukemia, NK-Cell Lymphoma, Aggressive NK-cell Leukemia.

What interventions are being tested in trial NCT05978141?

The interventions under investigation include: Optional Blood Sample and Nail Sample (OTHER).

Who is sponsoring clinical trial NCT05978141?

This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05978141 being conducted?

This trial has 20 study locations across California, Colorado, Connecticut, Florida, Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for T-Cell Lymphoma

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05978141's enrollment target sits among peer trials

1,000 1st of 15 higher than 15 of 15 other T-Cell Lymphoma trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other T-Cell Lymphoma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00018044 · 1,000 participants

    Study of Mycobacterial Infections

  • NCT01036581 · 1,000 participants · NA

    Advanced Functional and Structural MRI Techniques for Neuropharmacological Imaging

  • NCT01192048 · 1,000 participants

    Genetics of Congenital Heart Disease

  • NCT01553214 · 1,000 participants · Phase 4

    Improving White Blood Cell Collection From Healthy Donors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

More recruiting context for NCT05978141

Source: ClinicalTrials.gov NCT05978141, the US trial registry maintained by the National Library of Medicine. NCT05978141 (large enrollment · wide site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.